Publications by authors named "Rachel Netahe Asiniwasis"
Article Synopsis
- The American Academy of Allergy, Asthma, and Immunology is updating its guidelines for managing atopic dermatitis (AD) due to advancements in treatment and evidence methods since the last update in 2012.
- A multidisciplinary panel, including AD specialists and patient representatives, created evidence-based guidelines emphasizing equity, diversity, and minimizing conflicts of interest while reviewing systematic evidence.
- The panel produced 25 recommendations to help manage AD and included practical implementation resources for patients, covering various treatment options like topical corticosteroids, calcineurin inhibitors, and more.
Article Synopsis
- The study aims to synthesize patient and caregiver values and preferences in managing atopic dermatitis (AD) to aid the development of clinical guidelines by relevant allergy associations.* ! -
- A thorough review of numerous studies revealed that participants generally favor starting with nonmedical treatments and are concerned about side effects from medications, highlighting the importance of a strong patient-clinician relationship.* ! -
- Findings indicate that patients prefer treatments that are odorless, minimally visible, and have a low impact on daily activities, with a specific emphasis on relieving itching and burning sensations.* !
Article Synopsis
- Atopic dermatitis (AD) is influenced by skin barrier issues, immune responses, and factors like allergens, but the specific role of environmental allergens in aggravating AD is not well understood.
- A study reviewed 23 randomized controlled trials to assess the benefits and harms of allergen immunotherapy (AIT) like subcutaneous (SCIT) and sublingual (SLIT) therapies for easing AD symptoms and improving quality of life (QoL).
- Results indicated that both SCIT and SLIT significantly improve AD severity and QoL but also lead to more adverse events, suggesting that while they can help manage symptoms, there are trade-offs to consider.
Background: Bleach bathing is frequently recommended to treat atopic dermatitis (AD), but its efficacy and safety are uncertain.
Objective: To systematically synthesize randomized controlled trials (RCTs) addressing bleach baths for AD.
Methods: We searched MEDLINE, EMBASE, CENTRAL, and GREAT from inception to December 29, 2021, for RCTs assigning patients with AD to bleach vs no bleach baths.
Canadian Indigenous youth continue to face higher rates of health disparities than their non-Indigenous counterparts. In dermatology, this includes a high burden of atopic dermatitis, as well as secondary skin and soft tissue infections. Unfortunately, numerous barriers to treatment exist, including systemic and institutional racism, poverty, crowded housing conditions on reserves, access and cost of basic skin care regimens, and clean water access.
View Article and Find Full Text PDF